U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07009353) titled 'A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body' on May 05.
Brief Summary: The purpose of this study is to learn how quickly and to what extent the study medicine (PF-07054894) is absorbed, broken down, and eliminated from the body.
Study Start Date: June 19
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: PF-07054894
Cohort 1 Period 1 - Oral [cyclobutenyl-14C]PF-07054894 under fasted state. Cohort 1 Period 2: Oral unlabeled PF-07054894 followed by IV [cyclobutenyl-14C]PF-07054894 fusion over approximately 15 minutes at approximately 1.5 hours after the administration o...